AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Rabkro-IV Injection

Prescription Icon
Prescription Required

Marketer

Krishgir Pharmaceuticals Pvt Ltd

Salt Composition

Rabeprazole (20mg)

Overview Rabkro-IV Injection

Intravenous Rabkro is a medication that diminishes gastric acid production. It treats acid-related gastrointestinal disorders, including acid reflux, indigestion, peptic ulcers, and other conditions stemming from excessive stomach acid. Its rapid action offers prompt relief from acidity. Used prophylactically against stress ulcers in critically ill patients, it's also administered pre-anesthesia to mitigate aspiration risks. Classified as a proton pump inhibitor (PPI), it's intravenously administered by a healthcare professional only when deemed superior to oral administration by your physician. Dosage is tailored to your condition and response. Continue the prescribed treatment course, even with rapid symptom improvement. Smaller, more frequent meals, alongside avoidance of caffeine, spicy, and fatty foods, can enhance treatment efficacy. Commonly reported side effects include nausea, vomiting, headache, dizziness, flatulence, diarrhea, abdominal pain, and thrombophlebitis (vein inflammation). While usually mild, persistent or bothersome effects warrant medical attention. Prolonged use may increase adverse event risk. Use exceeding one year, particularly at higher doses, may elevate bone fracture risk. Discuss bone loss prevention strategies, such as calcium and vitamin D supplementation, with your doctor. Hypomagnesemia (low blood magnesium) has been noted in some patients after three months or more of use, potentially causing fatigue, confusion, dizziness, muscle spasms, and arrhythmia. Your doctor may monitor your magnesium levels. Intravenous Rabkro is contraindicated for certain individuals. Inform your doctor of severe liver disease, HIV medication use, prior allergic reactions to similar drugs, or pre-existing osteoporosis before commencing treatment. Pregnant or breastfeeding women should seek medical counsel. Alcohol should be avoided due to its acid-stimulating effect. Refrain from operating machinery or driving if dizziness or drowsiness occur.

Uses of Rabkro-IV Injection

Management of acid indigestion and peptic ulcers

Major Benefits of Rabkro-IV Injection:

This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.

Common Side effects of Rabkro-IV Injection:

  • Nausea
  • Vomiting
  • Headache
  • Dizziness
  • Flatulence
  • Diarrhea
  • Stomach pain
  • Thrombophlebitis

How to use Rabkro-IV Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

How Rabkro-IV Injection works:

Stomach acid production is decreased by Rabkro-IV Injection, a proton pump inhibitor (PPI), thus alleviating heartburn and acid indigestion.

SAFETY ADVICE

AlcoholAlcoholCAUTION

Use of alcohol with Rabkro-IV Injection requires careful consideration. Physician consultation is recommended.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Rabkro-IV Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Use of Rabkro-IV Injection while breastfeeding is likely inadvisable. Available human data indicates potential drug transfer to breast milk, posing a risk to the infant.

DrivingDrivingCONSULT YOUR DOCTOR

The impact of Rabkro-IV Injection on driving ability is undetermined. Refrain from operating a vehicle if experiencing symptoms impairing concentration or reaction time.

KidneyKidneySAFE IF PRESCRIBED

Rabkro-IV Injection poses no safety concerns for patients with renal impairment, and no dosage modification is necessary.

LiverLiverCAUTION

Exercise caution when administering Rabkro-IV Injection to individuals with advanced hepatic impairment. Dosage modification of Rabkro-IV Injection might be necessary. Physician consultation is recommended.

What if you forget to take Rabkro-IV Injection :

Omit a Rabkro-IV Injection dose? Seek your physician's advice.

Facts to Know About Rabkro-IV Injection

LabelValue
Chemical Classification Benzimidazole Sulfoxide
Developing Habits No.
Treatment Category Gastrointestinal system
Behavioral Class PPIs (proton pump inhibitors)

FAQs on Rabkro-IV Injection

Rabkro-IV Injection treats stomach and duodenal ulcers, reflux esophagitis (GERD), and Zollinger-Ellison syndrome (ZES) by decreasing stomach acid production, thereby relieving symptoms. It also prevents acid-related complications from painkiller use and stress ulcers in critically ill patients. Furthermore, it's used pre-anesthesia to reduce aspiration risks such as lung injury.
For best results, take Rabkro-IV Injection one hour before eating. While using this medication, minimize consumption of spicy, fatty foods, caffeinated beverages (tea, coffee, cola), and alcohol, as these may exacerbate symptoms.
Prolonged Rabkro-IV Injection use can lead to osteoporosis (bone thinning) by reducing calcium absorption. This deficiency increases the risk of fractures in the hip, wrist, or spine. To mitigate this, ensure sufficient dietary calcium or take supplements as your doctor recommends.
For optimal results with Rabkro-IV Injection, combine it with a healthy lifestyle. Regular exercise and a balanced diet are recommended. Consult a dietician for personalized dietary guidance. To minimize nighttime symptoms, avoid eating within three hours of bedtime. Limit or eliminate spicy, fatty foods, caffeine (tea, coffee, cola), alcohol, and tobacco, as these may exacerbate your condition.
No, consuming alcohol with Rabkro-IV Injection is not recommended. While alcohol doesn't directly interfere with the injection's function, it can heighten stomach acid production, potentially exacerbating your symptoms.
Antacids can be taken with Rabkro-IV Injection, but allow a 2-hour interval between administrations.
Rabkro-IV Injection takes effect within an hour, reaching peak effectiveness in two to four hours. Noticeable improvement is expected within two to three days, though complete symptom relief may require up to four weeks.
Continue taking Rekool as prescribed until the treatment is finished, even if you feel better sooner. Rabkro-IV Injection is administered intravenously for up to 7 days only if oral medication is impossible. Intravenous administration ceases once oral Rekool is feasible, and oral medication will then be prescribed. Always follow your doctor's instructions for Rabkro-IV Injection to optimize treatment outcomes.
Rabkro-IV Injection is generally well-tolerated, with most users experiencing no side effects. Follow your doctor's instructions for optimal results.
Rabkro-IV Injection
86
MRP 105
18% off